Gaia posted double-digit year-over-year revenue growth, driven in part by an increase in the streaming video provider’s ...

OnKure's drug candidate pipeline is highlighted by OKI-219, a selective PI3K alpha H1047R inhibitor for the treatment of certain types of breast cancer that began clinical trials in February 2024.

Cowboys secured one of their better playmakers in returner KaVontae Turpin on Tuesday. He signed a three-year deal that two people with knowledge of the negotiations ...